Virtus Investment Advisers, Inc. has filed its 13F form on February 14, 2025 for Q4 2024 where it was disclosed a total value porftolio of $119 Million distributed in 360 stocks.
Among their holdings, we can observe that their the top five positions include companies like: Icici Bank LTD with a value of $3.75M, Virtus ETF Tr Ii Virtus Duff & with a value of $2.74M, Apple Inc. with a value of $2.06M, Microsoft Corp with a value of $2.02M, and Primoris Services Corp with a value of $1.86M.
Examining the 13F form we can see an decrease of $597K in the current position value, from $119M to 119M .
Virtus Investment Advisers, Inc. is based out at Hartford, CT
Below you can find more details about Virtus Investment Advisers, Inc. portfolio as well as his latest detailed transactions.
Portfolio value
$119 Million
Technology: $22.5 Million
Financial Services: $20.6 Million
Industrials: $18.7 Million
Healthcare: $17.2 Million
Consumer Cyclical: $9.61 Million
Consumer Defensive: $8.32 Million
Utilities: $6.32 Million
Real Estate: $4.52 Million
Other: $11.1 Million
Stock
Market Cap.
Holding Value (Reported)
# of Shares.
Last Trade
Trade History
-
$0
0.0% of portfolio
-
Q4 2024
New
-
$0
0.0% of portfolio
-
Q4 2024
New
-
$0
0.0% of portfolio
-
Q1 2024
New
-
$0
0.0% of portfolio
-
Q4 2024
New
-
$0
0.0% of portfolio
-
Q4 2023
New
-
$0
0.0% of portfolio
-
Q4 2023
New
-
$0
0.0% of portfolio
-
Q3 2024
New
Amalgamated Financial Corp
-
$0
0.0% of portfolio
-
Q2 2024
Reduced 74.15%
-
$0
0.0% of portfolio
-
Q4 2024
Reduced 61.54%
American Airlines Group Inc
-
$0
0.0% of portfolio
-
Q4 2024
New
-
$0
0.0% of portfolio
-
Q4 2024
New
-
$0
0.0% of portfolio
-
Q2 2024
New
Alnylam Pharmaceuticals Inc
-
$0
0.0% of portfolio
-
Q4 2023
New
-
$0
0.0% of portfolio
-
Q4 2024
New
-
$0
0.0% of portfolio
-
Q2 2024
New
-
$0
0.0% of portfolio
-
Q4 2023
New
-
$0
0.0% of portfolio
-
Q2 2024
New
-
$0
0.0% of portfolio
-
Q3 2024
Added 40.0%
-
$0
0.0% of portfolio
-
Q4 2023
New
-
$0
0.0% of portfolio
-
Q4 2023
New
-
$0
0.0% of portfolio
-
Q1 2024
New
-
$0
0.0% of portfolio
-
Q4 2023
New
-
$0
0.0% of portfolio
-
Q4 2024
New
-
$0
0.0% of portfolio
-
Q2 2024
New
-
$0
0.0% of portfolio
-
Q4 2024
Added 21.88%
-
$0
0.0% of portfolio
-
Q4 2023
New
-
$0
0.0% of portfolio
-
Q4 2024
New
-
$0
0.0% of portfolio
-
Q2 2024
New
-
$0
0.0% of portfolio
-
Q4 2024
New
-
$0
0.0% of portfolio
-
Q4 2023
New
-
$0
0.0% of portfolio
-
Q4 2024
Added 86.36%
-
$0
0.0% of portfolio
-
Q4 2023
New
-
$0
0.0% of portfolio
-
Q3 2024
Reduced 21.88%
-
$0
0.0% of portfolio
-
Q4 2024
New
-
$0
0.0% of portfolio
-
Q1 2024
New
-
$0
0.0% of portfolio
-
Q4 2024
Added 180.0%
-
$0
0.0% of portfolio
-
Q4 2024
New
Halozyme Therapeutics Inc
-
$0
0.0% of portfolio
-
Q4 2024
Added 71.05%
-
$0
0.0% of portfolio
-
Q4 2023
New
-
$0
0.0% of portfolio
-
Q3 2024
New
-
$0
0.0% of portfolio
-
Q4 2023
New
$226B
$1,000
0.0% of portfolio
13
Q4 2024
Reduced 99.58%
-
$0
0.0% of portfolio
-
Q4 2024
Reduced 22.45%
-
$0
0.0% of portfolio
-
Q4 2023
New
-
$0
0.0% of portfolio
-
Q4 2024
New
-
$0
0.0% of portfolio
-
Q3 2024
New
Ventas Rlty LTD Partnership
-
$0
0.0% of portfolio
-
Q3 2024
New
-
$0
0.0% of portfolio
-
Q3 2024
New
-
$0
0.0% of portfolio
-
Q4 2024
New
-
$0
0.0% of portfolio
-
Q4 2023
New